Related references
Note: Only part of the references are listed.Relevance of Latent TB Infection in Areas of High TB Prevalence
Surendra K. Sharma et al.
CHEST (2012)
Correlation of Mycobacterium Tuberculosis Specific and Non-Specific Quantitative Th1 T-Cell Responses with Bacillary Load in a High Burden Setting
Grant Theron et al.
PLOS ONE (2012)
Thibela TB: Design and methods of a cluster randomised trial of the effect of community-wide isoniazid preventive therapy on tuberculosis amongst gold miners in South Africa
Katherine L. Fielding et al.
CONTEMPORARY CLINICAL TRIALS (2011)
Immunological biomarkers of tuberculosis
Gerhard Walzl et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Tuberculosis treatment effect on T-cell interferon-γ responses to Mycobacterium tuberculosis-specific antigens
C. B. E. Chee et al.
EUROPEAN RESPIRATORY JOURNAL (2010)
Tuberculosis case-contact research in endemic tropical settings: design, conduct, and relevance to other infectious diseases
Philip C. Hill et al.
LANCET INFECTIOUS DISEASES (2010)
Decay Kinetics of an Interferon Gamma Release Assay with Anti-Tuberculosis Therapy in Newly Diagnosed Tuberculosis Cases
Ifedayo M. O. Adetifa et al.
PLOS ONE (2010)
Commercial Interferon Gamma Release Assays Compared to the Tuberculin Skin Test for Diagnosis of Latent Mycobacterium tuberculosis Infection in Childhood Contacts in the Gambia
Ifedayo M. O. Adetifa et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2010)
Point-of-care Arkansas method for measuring adherence to treatment with isoniazid
Renata L. Guerra et al.
RESPIRATORY MEDICINE (2010)
Serial interferon-gamma release assays after rifampicin prophylaxis in a tuberculosis outbreak
Seung Heon Lee et al.
RESPIRATORY MEDICINE (2010)
In Vivo and In Vitro Effects of Antituberculosis Treatment on Mycobacterial Interferon-γ T Cell Response
Ilaria Sauzullo et al.
PLOS ONE (2009)
Within-Subject Variability of Interferon-g Assay Results for Tuberculosis and Boosting Effect of Tuberculin Skin Testing: A Systematic Review
Richard N. van Zyl-Smit et al.
PLOS ONE (2009)
Incidence of Tuberculosis and the Predictive Value of ELISPOT and Mantoux Tests in Gambian Case Contacts
Philip C. Hill et al.
PLOS ONE (2008)
Comparison of two interferon gamma release assays in the diagnosis of Mycobacterium tuberculosis infection and disease in The Gambia
Ifedayo M. O. Adetifa et al.
BMC INFECTIOUS DISEASES (2007)
Longitudinal assessment of an ELISPOT test for Mycobacterium tuberculosis infection
Philip C. Hill et al.
PLOS MEDICINE (2007)
Meta-analysis: New tests for the diagnosis of latent tuberculosis infection: Areas of uncertainty and recommendations for research
Dick Menzies et al.
ANNALS OF INTERNAL MEDICINE (2007)
Latent tuberculosis infection treatment and T-Cell responses to Mycobacterium tuberculosis-specific antigens
Cynthia B. E. Chee et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Dynamic antigen-specific point-source exposure to T-cell responses after Mycobacterium tuberculosis
Katie Ewer et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Sub-Saharan African Coding Sequence Variation and Haplotype Diversity at the NAT2 Gene
Etienne Patin et al.
HUMAN MUTATION (2006)
Comparison of enzyme-linked immunospot assay and tuberculin skin test in healthy children exposed to Mycobacterium tuberculosis
PC Hill et al.
PEDIATRICS (2006)
Reversion of the ELISPOT test after treatment in Gambian tuberculosis cases
Alexander M. Aiken et al.
BMC INFECTIOUS DISEASES (2006)
Effect of treatment of latent tuberculosis infection on the T cell response to Mycobacterium tuberculosis antigens
KA Wilkinson et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Enzyme-linked immunospot assay responses to early secretory antigenic target 6, culture filtrate protein 10, and purified protein derivative among children with tuberculosis: Implications for diagnosis and monitoring of therapy
MP Nicol et al.
CLINICAL INFECTIOUS DISEASES (2005)
Considerations in the evaluation of surrogate endpoints in clinical trials: Summary of a National Institutes of Health Workshop
VG De Gruttola et al.
CONTROLLED CLINICAL TRIALS (2001)
Share Paper
